Fundz

Syndax Pharmaceuticals Appoints Aaron A. Ondrey as Chief Financial Officer

PUBLIC · SNDXNov 02, 2026
New to company · from Beren Therapeutics“Most recently, he served as Chief Financial Officer of Beren Therapeutics, where he oversaw finance, investor relations, and manufacturing operations.”

Position

Chief Financial Officer

Company

Syndax Pharmaceuticals

Aaron A. Ondrey
New YorkBiotechnologyHealthcarePharmaceuticalBiopharma

Description

Syndax Pharmaceuticals announces the appointment of Aaron A. Ondrey as Chief Financial Officer, effective November 9, 2026. Aaron brings over 25 years of experience in financial leadership within the biotechnology industry.

Who to call at Syndax Pharmaceuticals, and when

A new leader at Syndax Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Syndax Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syndax Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syndax Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syndax Pharmaceuticals

Location

New York, New York, United States

About

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syndax Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Steven
Likely contact at this company
••••••••@••••••••

See Steven's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Syndax Pharmaceuticals's next move

Learn about Strategic plan

Syndax Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.